Subject(s)
Critical Illness/nursing , Palliative Care/methods , Patient Education as Topic , Respiration Disorders/nursing , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle AgedABSTRACT
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity, mortality and resource use worldwide. The goal of this official American Thoracic Society (ATS)/European Respiratory Society (ERS) Research Statement is to describe evidence related to diagnosis, assessment, and management; identify gaps in knowledge; and make recommendations for future research. It is not intended to provide clinical practice recommendations on COPD diagnosis and management. Clinicians, researchers and patient advocates with expertise in COPD were invited to participate. A literature search of Medline was performed, and studies deemed relevant were selected. The search was not a systematic review of the evidence. Existing evidence was appraised and summarised, and then salient knowledge gaps were identified. Recommendations for research that addresses important gaps in the evidence in all areas of COPD were formulated via discussion and consensus. Great strides have been made in the diagnosis, assessment and management of COPD, as well as understanding its pathogenesis. Despite this, many important questions remain unanswered. This ATS/ERS research statement highlights the types of research that leading clinicians, researchers and patient advocates believe will have the greatest impact on patient-centred outcomes.
Subject(s)
Biomedical Research , Lung , Pulmonary Disease, Chronic Obstructive , Comorbidity , Consensus , Humans , Lung/pathology , Lung/physiopathology , Predictive Value of Tests , Pulmonary Disease, Chronic Obstructive/diagnosis , Pulmonary Disease, Chronic Obstructive/epidemiology , Pulmonary Disease, Chronic Obstructive/physiopathology , Pulmonary Disease, Chronic Obstructive/therapy , Respiratory Function Tests , Risk Factors , Risk Reduction Behavior , Severity of Illness Index , Treatment OutcomeABSTRACT
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity, mortality, and resource use worldwide. The goal of this official American Thoracic Society (ATS)/European Respiratory Society (ERS) research statement is to describe evidence related to diagnosis, assessment and management; identify gaps in knowledge; and make recommendations for future research. It is not intended to provide clinical practice recommendations on COPD diagnosis and management. Clinicians, researchers, and patient advocates with expertise in COPD were invited to participate. A literature search of Medline was performed, and studies deemed relevant were selected. The search was not a systematic review of the evidence. Existing evidence was appraised and summarised, and then salient knowledge gaps were identified. Recommendations for research that addresses important gaps in the evidence in all areas of COPD were formulated via discussion and consensus. Great strides have been made in the diagnosis, assessment and management of COPD, as well as understanding its pathogenesis. Despite this, many important questions remain unanswered. This ATS/ERS research statement highlights the types of research that leading clinicians, researchers, and patient advocates believe will have the greatest impact on patient-centred outcomes.
Subject(s)
Biomedical Research/organization & administration , Evidence-Based Medicine , Practice Guidelines as Topic , Pulmonary Disease, Chronic Obstructive/therapy , Societies, Medical/organization & administration , Disease Management , Europe , Female , Humans , Male , Prognosis , Pulmonary Disease, Chronic Obstructive/diagnosis , Pulmonary Disease, Chronic Obstructive/mortality , Surveys and Questionnaires , Survival Analysis , United StatesABSTRACT
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity, mortality, and resource use worldwide. The goal of this Official American Thoracic Society (ATS)/European Respiratory Society (ERS) Research Statement is to describe evidence related to diagnosis, assessment, and management; identify gaps in knowledge; and make recommendations for future research. It is not intended to provide clinical practice recommendations on COPD diagnosis and management. METHODS: Clinicians, researchers, and patient advocates with expertise in COPD were invited to participate. A literature search of Medline was performed, and studies deemed relevant were selected. The search was not a systematic review of the evidence. Existing evidence was appraised and summarized, and then salient knowledge gaps were identified. RESULTS: Recommendations for research that addresses important gaps in the evidence in all areas of COPD were formulated via discussion and consensus. CONCLUSIONS: Great strides have been made in the diagnosis, assessment, and management of COPD as well as understanding its pathogenesis. Despite this, many important questions remain unanswered. This ATS/ERS Research Statement highlights the types of research that leading clinicians, researchers, and patient advocates believe will have the greatest impact on patient-centered outcomes.
Subject(s)
Biomedical Research/organization & administration , Pulmonary Disease, Chronic Obstructive/diagnosis , Pulmonary Disease, Chronic Obstructive/therapy , Societies, Medical/organization & administration , Europe , Evidence-Based Medicine/methods , Evidence-Based Medicine/organization & administration , Humans , Organizational Objectives , Policy Making , United StatesABSTRACT
The importance of exercise for pulmonary patients is unquestioned. Decreased functional status has been attributed to increased hospitalizations, leading to further decreases in functionality, decreased quality of life and increased mortality. Despite known benefits of pulmonary rehabilitation, recruitment and retention of program participants can be a challenge. Alternatives to traditional pulmonary rehabilitation are reviewed with an emphasis on physical activity, exacerbation awareness and a reduction in hospital admissions.
Subject(s)
Pulmonary Disease, Chronic Obstructive/rehabilitation , Humans , Patient Care Management , Patient Readmission , Pulmonary Disease, Chronic Obstructive/mortality , Pulmonary Disease, Chronic Obstructive/physiopathology , Quality of Life , Rehabilitation/methods , Rehabilitation/organization & administrationABSTRACT
BACKGROUND: Pulmonary rehabilitation is recognized as a core component of the management of individuals with chronic respiratory disease. Since the 2006 American Thoracic Society (ATS)/European Respiratory Society (ERS) Statement on Pulmonary Rehabilitation, there has been considerable growth in our knowledge of its efficacy and scope. PURPOSE: The purpose of this Statement is to update the 2006 document, including a new definition of pulmonary rehabilitation and highlighting key concepts and major advances in the field. METHODS: A multidisciplinary committee of experts representing the ATS Pulmonary Rehabilitation Assembly and the ERS Scientific Group 01.02, "Rehabilitation and Chronic Care," determined the overall scope of this update through group consensus. Focused literature reviews in key topic areas were conducted by committee members with relevant clinical and scientific expertise. The final content of this Statement was agreed on by all members. RESULTS: An updated definition of pulmonary rehabilitation is proposed. New data are presented on the science and application of pulmonary rehabilitation, including its effectiveness in acutely ill individuals with chronic obstructive pulmonary disease, and in individuals with other chronic respiratory diseases. The important role of pulmonary rehabilitation in chronic disease management is highlighted. In addition, the role of health behavior change in optimizing and maintaining benefits is discussed. CONCLUSIONS: The considerable growth in the science and application of pulmonary rehabilitation since 2006 adds further support for its efficacy in a wide range of individuals with chronic respiratory disease.
Subject(s)
Lung Diseases/rehabilitation , Bronchodilator Agents/therapeutic use , Exercise Therapy , Humans , Lung/physiopathology , Lung Diseases/physiopathology , Lung Diseases/therapy , Motor Activity , Pulmonary Disease, Chronic Obstructive/physiopathology , Pulmonary Disease, Chronic Obstructive/rehabilitationABSTRACT
The multidisciplinary treatment of pulmonary rehabilitation (PR), which includes exercise training, self-management education, and psychosocial and nutritional intervention, is now a standard of care for chronic obstructive pulmonary disease (COPD) and has been incorporated into major guidelines. We must now focus efforts on improving its impact and widening its applicability. What is the direction of PR; where does it fit in the comprehensive care of the COPD patient; and how can clinicians best apply this important intervention? This was the charge of the roundtable discussion, Pulmonary Rehabilitation: Moving Forward, involving 20 experts from North America and Europe, which was convened in Fort Lauderdale, Florida, in early 2008. It is not meant to be an exhaustive review; rather, this report summarizes the roundtable proceedings, while providing direction to best position PR into the continuum of COPD care. By consensus, it was agreed upon that although PR is effective for other chronic respiratory diseases, the discussion focus was COPD since most of the evidence base and patient referral are for this disease. These proceedings provide insight into 3 broad areas appropriate for investigation or implementation: positioning PR in an integrated care model for COPD patients; improving the effectiveness of this intervention; and expanding the recognition, application, and accessibility to PR. It is the hope that this document will provide a catalyst for clinicians, investigators, and healthcare policy makers to help realize these goals as well as serve to suggest important areas for future research and development in PR.
Subject(s)
Delivery of Health Care, Integrated/trends , Pulmonary Disease, Chronic Obstructive/rehabilitation , Europe , Humans , Patient Education as Topic/trends , Program Evaluation/trends , United StatesABSTRACT
BACKGROUND: Exercise has important benefits for individuals with chronic obstructive pulmonary disease (COPD). However, to sustain long-term benefits of exercise, adherence is needed. Adherence requires self-regulation. No scale is available to measure exercise self-regulation in individuals with COPD. OBJECTIVES: We developed and tested the reliability and validity of an "Exercise Self-Regulatory Efficacy Scale (Ex-SRES)" for individuals with COPD. METHODS: A convenience sample of 109 subjects with COPD was recruited. Cronbach's alpha was used to assess the internal consistency reliability of the Ex-SRES. Subjects' exercise behaviors and health status were used to assess the validity of the Ex-SRES. RESULTS: The Ex-SRES demonstrated evidence of reliability (Cronbach's alpha .917) and validity (correlation with minutes of exercise per week [r = .41; P < .0001] and health status [r = .37; P < .0001]). CONCLUSION: The Ex-SRES is a short (16-items) and easy to use questionnaire that may be valuable for assessing patients in clinical settings, as well as for future research studies in behaviors related to exercise.